Direct Screening qPCR Assay for SARS-CoV-2 Spike Δ 69-70 (“UK” Variant) (RUO)

We are pleased to announce the immediate availability of the UltraGene Assay SARS-CoV-2 N / Spike Δ 69-70, a direct qPCR assay to be used on already SARS-CoV-2 positive samples (no need to do additional RNA isolation) to screen the SARS-CoV-2 Spike protein 69-70 amino-acid deletion, synonymous of the B.1.1.7 – ”UK Variant” lineage (possibly associated with an increased infectivity and transmissibility).

For more information please contact us at the following email address:

contact@ablsa.com